Trial · NCT00634244
Adverse events447
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 447
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anemia | Blood and lymphatic system disorders | Arm A (Carboplatin+Topotecan Hydrochloride) | 34 | 35 | |
| other | Anemia | Blood and lymphatic system disorders | Arm B (Alvocidib+Cytarabine+Mitoxantrone) | 32 | 36 | |
| other | Anemia | Blood and lymphatic system disorders | Arm C (Sirolimus+Mitoxantrone+Etoposide+Cytarabine) | 20 | 20 | |
| other | Sinus tachycardia | Cardiac disorders | Arm A (Carboplatin+Topotecan Hydrochloride) | 0 | 35 | |
| other | Sinus tachycardia | Cardiac disorders | Arm B (Alvocidib+Cytarabine+Mitoxantrone) | 4 | 36 | |
| other | Sinus tachycardia | Cardiac disorders | Arm C (Sirolimus+Mitoxantrone+Etoposide+Cytarabine) | 2 | 20 | |
| other | Chills | General disorders | Arm A (Carboplatin+Topotecan Hydrochloride) | 1 | 35 | |
| other | Chills | General disorders | Arm B (Alvocidib+Cytarabine+Mitoxantrone) | 10 | 36 | |
| other | Chills | General disorders | Arm C (Sirolimus+Mitoxantrone+Etoposide+Cytarabine) | 4 | 20 | |
| other | Edema limbs | General disorders | Arm A (Carboplatin+Topotecan Hydrochloride) | 5 | 35 | |
| other | Edema limbs | General disorders | Arm B (Alvocidib+Cytarabine+Mitoxantrone) | 8 | 36 | |
| other | Edema limbs | General disorders | Arm C (Sirolimus+Mitoxantrone+Etoposide+Cytarabine) | 4 | 20 | |
| other | Fatigue | General disorders | Arm A (Carboplatin+Topotecan Hydrochloride) | 16 | 35 | |
| other | Fatigue | General disorders | Arm B (Alvocidib+Cytarabine+Mitoxantrone) | 12 | 36 | |
| other | Fatigue | General disorders | Arm C (Sirolimus+Mitoxantrone+Etoposide+Cytarabine) | 9 | 20 | |
| other | Fever | General disorders | Arm A (Carboplatin+Topotecan Hydrochloride) | 5 | 35 | |
| other | Fever | General disorders | Arm B (Alvocidib+Cytarabine+Mitoxantrone) | 2 | 36 | |
| other | Fever | General disorders | Arm C (Sirolimus+Mitoxantrone+Etoposide+Cytarabine) | 0 | 20 | |
| other | Pain | General disorders | Arm A (Carboplatin+Topotecan Hydrochloride) | 0 | 35 | |
| other | Pain | General disorders | Arm B (Alvocidib+Cytarabine+Mitoxantrone) | 2 | 36 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00634244/events